Related references
Note: Only part of the references are listed.Epidemiology of glaucoma: what's new?
Colin Cook et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2012)
The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes
Maria Bafa et al.
ACTA OPHTHALMOLOGICA (2011)
Effectiveness of Dorzolamide-Timolol (COSOPT) in Patients Who Were Treatment Naive for Open-Angle Glaucoma or Ocular Hypertension: The COSOPT First-Line Study
Andrew C. S. Crichton et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
The Effect of Prostaglandin Analogs and Prostamide on Central Corneal Thickness
Marcelo Hatanaka et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Torsten Schlote et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Comparison of the effects of latanoprost and bimatoprost on central corneal thickness
Emine Sen et al.
JOURNAL OF GLAUCOMA (2008)
Update on the Mechanism of Action of Topical Prostaglandins for Intraocular Pressure Reduction
Carol B. Toris et al.
SURVEY OF OPHTHALMOLOGY (2008)
Central corneal thickness as a risk factor for advanced glaucoma damage
LW Herndon et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues
NA Sharif et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Travoprost: A potent ocular hypotensive agent
AM Al-Jazzaf et al.
DRUGS OF TODAY (2003)
Share Paper
